IPCA Laboratories Ltd banner

IPCA Laboratories Ltd
NSE:IPCALAB

Watchlist Manager
IPCA Laboratories Ltd Logo
IPCA Laboratories Ltd
NSE:IPCALAB
Watchlist
Price: 1 579.9 INR 1.5%
Market Cap: ₹400.8B

Relative Value

The Relative Value of one IPCALAB stock under the Base Case scenario is hidden INR. Compared to the current market price of 1 579.9 INR, IPCA Laboratories Ltd is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

IPCALAB Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Multiples Across Competitors

IPCALAB Competitors Multiples
IPCA Laboratories Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
IPCA Laboratories Ltd
NSE:IPCALAB
404.2B INR 4.2 44.1 20.5 26
US
Eli Lilly and Co
NYSE:LLY
934.5B USD 14.3 45.3 30.5 32.5
US
Johnson & Johnson
NYSE:JNJ
585.6B USD 6.2 21.8 15.2 18.6
CH
Roche Holding AG
SIX:ROG
257.3B CHF 4.2 19.9 11.8 13.3
UK
AstraZeneca PLC
LSE:AZN
223.5B GBP 5.1 29.2 16.2 22.8
CH
Novartis AG
SIX:NOVN
233.6B CHF 5.3 21.5 13.3 17.1
US
Merck & Co Inc
NYSE:MRK
285.6B USD 4.4 15.6 9.7 11.8
IE
Endo International PLC
LSE:0Y5F
218B USD 94 -74.6 344.9 865
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 3.6 10.8 8 9.4
US
Pfizer Inc
NYSE:PFE
151.3B USD 2.4 19.5 7.5 10
US
Bristol-Myers Squibb Co
NYSE:BMY
120.2B USD 2.5 17.1 7.2 8.8
P/E Multiple
Earnings Growth PEG
IN
IPCA Laboratories Ltd
NSE:IPCALAB
Average P/E: 24.5
44.1
31%
1.4
US
Eli Lilly and Co
NYSE:LLY
45.3
32%
1.4
US
Johnson & Johnson
NYSE:JNJ
21.8
7%
3.1
CH
Roche Holding AG
SIX:ROG
19.9
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.2
26%
1.1
CH
Novartis AG
SIX:NOVN
21.5
14%
1.5
US
Merck & Co Inc
NYSE:MRK
15.6
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -74.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.8
1%
10.8
US
Pfizer Inc
NYSE:PFE
19.5
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17.1
16%
1.1
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IN
IPCA Laboratories Ltd
NSE:IPCALAB
Average EV/EBITDA: 44.1
20.5
16%
1.3
US
Eli Lilly and Co
NYSE:LLY
30.5
22%
1.4
US
Johnson & Johnson
NYSE:JNJ
15.2
2%
7.6
CH
Roche Holding AG
SIX:ROG
11.8
6%
2
UK
AstraZeneca PLC
LSE:AZN
16.2
13%
1.2
CH
Novartis AG
SIX:NOVN
13.3
5%
2.7
US
Merck & Co Inc
NYSE:MRK
9.7
3%
3.2
IE
E
Endo International PLC
LSE:0Y5F
344.9
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8
1%
8
US
Pfizer Inc
NYSE:PFE
7.5
-9%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett